EcoDrugPlus


Synonyms	Xenon
Status
Molecule Category	UNKNOWN
ATC	N01AX15
UNII	3H3U766W84
EPA CompTox	DTXSID5064700

Synonyms

Xenon

Status

Molecule Category

UNKNOWN

ATC

N01AX15

UNII

3H3U766W84

EPA CompTox

DTXSID5064700


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70


InChI Key	FHNFHKCVQCLJFQ-UHFFFAOYSA-N
Smiles	[Xe]
InChI	InChI=1S/Xe

InChI Key

FHNFHKCVQCLJFQ-UHFFFAOYSA-N

Smiles

[Xe]

InChI

InChI=1S/Xe

Property Name	Value
Molecular Formula	Xe
Molecular Weight	131.29
AlogP	None
Hydrogen Bond Acceptor	None
Hydrogen Bond Donor	None
Number of Rotational Bond	None
Polar Surface Area	None
Molecular species	None
Aromatic Rings	None
Heavy Atoms	None

Property Name

Value

Molecular Formula

Molecular Weight

131.29

AlogP

None

Hydrogen Bond Acceptor

None

Hydrogen Bond Donor

None

Number of Rotational Bond

None

Polar Surface Area

None

Molecular species

None

Aromatic Rings

None

Heavy Atoms

None

Resources	Reference
ChEBI	49957
ChEMBL	CHEMBL1236802
DrugBank	DB13453
DrugCentral	4369
FDA SRS	3H3U766W84
KEGG	C13373
PDB	XE
PubChem	23991
SureChEMBL	SCHEMBL16984

Resources

Reference

ChEBI

ChEMBL

DrugBank

DrugCentral

FDA SRS

KEGG

PDB

PubChem

23991

SureChEMBL

SCHEMBL16984


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

XENON

Structure

Physicochemical Descriptors

Cross References